MET and metabolic dysfunction-associated steatohepatitis: Their results showed the inhibition of inflammatory cell infiltration, amelioration of fibrosis, induction of the proliferation of human hepatocytes, and the restoration of the HGF-Met axis, which they reported to be blocked in human NASH.65